ENTITY
Pharmesis International

Pharmesis International (PHM SP)

8
Analysis
Health Care • Singapore
Pharmesis International Ltd. is an investment holding company specializing in the research, development, production, sale, and marketing of Western medicine and Traditional Chinese Medicine (TCM) formulated products. The company offers Western medicine under the Kinna brand and TCM products under the Longlife brand, primarily targeting liver and gall bladder illnesses. It was founded in 1996 and is headquartered in Singapore.
more
•10 Jun 2020 00:00•Exchange-sponsored

Investor Participation in Healthcare Stocks has Surged in 2020

In the 2020 YTD, the iEdge SG All Healthcare Index has climbed 35% bringing its annualised total return since the end of 2010 to 9.2%. The...

Share
•19 May 2020 00:00•Exchange-sponsored

Biolidics, iX Biopharma & Hyphens Pharma Outpace Peers in 2020 YTD

Singapore’s most traded primary-listed stocks that represent medical equipment manufacturing, biotech and pharmaceuticals all generated gains...

Share
•09 Jan 2019 00:00•Exchange-sponsored

Healthcare Sector’s Growth Prospects Draw Fund Flows

Singapore’s healthcare sector is typically viewed as defensive and poised to enjoy multi-year growth prospects. Between July and Dec 2018, the...

Share
bullish•Suntar Eco-City
•29 Aug 2017 15:24•Exchange-sponsored
Share
x